Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial

Authors

Institutions

Publication Details

Journal
Clinical Microbiology and Infection
Published
2025-02-06
DOI
https://doi.org/10.1016/j.cmi.2025.02.002
Citations
2
Primary Topic
COVID-19 Clinical Research Studies
Type
article
Field-Weighted Citation Impact
2.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial

Thomas A. Murray, Christina E. Barkauskas, Eleftherios E Mylonakis, Daniel Knox et al.
2 citations
Clinical Microbiology and Infection
COVID-19 Clinical Research Studies
2.79
article

Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial

Thomas A. Murray, Christina E. Barkauskas, Eleftherios E Mylonakis, Daniel Knox, John Williamson, Barnaby Edward Young, Nicole Engen, Jakob J Malin, Adit A. Ginde, Lianne Siegel, Jonathan Kitonsa, Nnakelu Eriobu, Wesley H. Self, Vasiliki Rapti, Tomas Ø. Jensen, Kami Kim, David Price, David M. Vock, Uriel Sandkovsky, Thomas L Holland, Srikanth Ramachandruni, Cavan Reilly, Alfredo J Mena Lora, Mamta K. Jain, Elizabeth S. Higgs, Ahmad Mourad, Jens Dilling Lundgren, G. Mathews, Roger Paredes, Gregory Grandits
article en
2 citations

Abstract

No abstract available for this paper.
Clinical Microbiology and InfectionVol. 31(6)
University of Copenhagen (DK), National Institutes of Health (US), University of Minnesota (US), Duke University (US), University of Cologne (DE), National and Kapodistrian University of Athens (GR), Kiryu University (JP), Royal Victoria Infirmary (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Tampa General Hospital (US), Baylor University Medical Center (US), Mount Elizabeth Novena Hospital (SG), Rigshospitalet (DK), Intermountain Medical Center (US), UNSW Sydney (AU), University of Illinois Chicago (US), University of Chicago (US), Clinical Research Institute (US), Southwestern Medical Center (US), Methodist Hospital (US), CHRISTUS Spohn Hospital Corpus Christi - Memorial (US), Department of Health (TW), Pulmonary and Allergy Associates (US), Institute of Human Virology (NG), Duke Medical Center (US), National Institute of Allergy and Infectious Diseases (US), Minnesota Department of Health (US), National Centre for Infectious Diseases (SG), Hospital Universitari Germans Trias i Pujol (ES), University Hospital Cologne (DE), Centre of Excellence for Health, Immunity and Infections (DK), Sotiria General Hospital (GR), Wake Forest University (US), The University of Texas Southwestern Medical Center (US), Vanderbilt University Medical Center (US), Uganda Virus Research Institute (UG), University of Colorado Denver (US)
U.S. Department of Health and Human Services, Pfizer, Gilead Sciences, Regeneron Pharmaceuticals, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 13%
COVID-19 Clinical Research Studies
2.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.